Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
Recruiting · NCT05311072 · Observational (researchers observe without assigning treatment) · Lead sponsor: China-Japan Friendship Hospital
View the official record on ClinicalTrials.gov →Interventions studied
pulmonary endarterectomy or balloon pulmonary angioplasty
What this trial is about
The Change Database is a prospective, observational multi-center disease registry, which will collect data on patients with chronic thromboembolic pulmonary hypertension (CTEPH) in China. It aims to illustrate the epidemiology, management and long-term outcomes of CTEPH.
Who can take part
Age range
14 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients must be diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH)
- Patients must be willing to provide informed consent
- Patients must meet the following criteria for CTEPH:
- a mean pulmonary artery pressures (mPAP) ≥20 mmHg combined with a pulmonary vascular resistance (PVR) ≥ 3 WU and pulmonary arterial wedge pressure (PAWP)≤ 15 mmHg documented at right heart catheterization with radiographic evidence of organized thrombi involving the pulmonary arteries after 3 months of effective anticoagulation.
Exclusion criteria
- Main cause of PH other than CTEPH
- Participation in a therapeutic clinical trial with an unknown drug;
- Withdrawal or lack of informed consent.
Where it is running
1 location listed.
- China-Japan Frendship hospital - Beijing, China